Galectin Therapeutics financial statements

갈렉틴 테라퓨틱스NASDAQ:GALT · Nasdaq · Healthcare · sector #16
$3.76+0.80%
2026-10-06 close · prelim

Galectin Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$42M.

Reported results

Galectin Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q